newsJuly 27, 2026·AI News Daily

How AI is shortening drug discovery timelines in China

Insilico Medicine has reduced the time needed to produce some drug development candidates to about one year by combining artificial intelligence with laboratory research in China, according to CEO Alex Zhavoronkov. The Hong Kong-listed company’s fastest programme reached candidate nomination in nine months, while its typical timeline is about 13 months, Zhavoronkov said. He said […] The post How AI is shortening drug discovery timelines in China appeared first on AI News.

Key Takeaways

•Insilico Medicine has reduced the time needed to produce some drug development candidates to about one year by combining artificial intelligence with laboratory research in China, according to CEO Alex Zhavoronkov
•This story was reported by AI News Daily, covering developments in the news space.
•AI advancements continue to reshape industries — read the full article on AI News Daily for complete coverage.

📖 Continue reading the full article:

Read Full Article on AI News Daily →

Share this article

X Facebook Reddit ☕ Support

TechCrunch AI

Anthropic’s Dario Amodei responds: doesn’t oppose open-weight models, but fears Chinese AI

Anthropic founder and CEO Dario Amodei made his views clear about open-weight models and China's growing AI capabilities.

Ars Technica

Microsoft unveils AI security tools it says outperform competing platforms

Microsoft says tools cost less than competing ones and outperform them, too.

TechCrunch AI

Satya Nadella says companies that trust one AI for everything may not survive

Companies without their own models — or without a layer of AI infrastructure known as AI gateways to separate their prompts from the model itself — will be in trouble, Nadella says.

TechCrunch AI

PSA: Your Claude shared chats and Artifacts may have ended up on Google

The issue appears to have originated from Claude’s “share chat” feature, which allows users to create links that enable anyone with the assigned URL view a conversation or project.

Discussion

Loading articles...

How AI is shortening drug discovery timelines in China

Key Takeaways

Related Articles

Anthropic’s Dario Amodei responds: doesn’t oppose open-weight models, but fears Chinese AI

Microsoft unveils AI security tools it says outperform competing platforms

Satya Nadella says companies that trust one AI for everything may not survive

PSA: Your Claude shared chats and Artifacts may have ended up on Google

Discussion

How AI is shortening drug discovery timelines in China

Key Takeaways

Related Articles

Anthropic’s Dario Amodei responds: doesn’t oppose open-weight models, but fears Chinese AI

Microsoft unveils AI security tools it says outperform competing platforms

Satya Nadella says companies that trust one AI for everything may not survive

PSA: Your Claude shared chats and Artifacts may have ended up on Google

Discussion

Related Articles

TechCrunch AI
Anthropic’s Dario Amodei responds: doesn’t oppose open-weight models, but fears Chinese AI
Anthropic founder and CEO Dario Amodei made his views clear about open-weight models and China's growing AI capabilities.

Ars Technica
Microsoft unveils AI security tools it says outperform competing platforms
Microsoft says tools cost less than competing ones and outperform them, too.

TechCrunch AI
Satya Nadella says companies that trust one AI for everything may not survive
Companies without their own models — or without a layer of AI infrastructure known as AI gateways to separate their prompts from the model itself — will be in trouble, Nadella says.

TechCrunch AI
PSA: Your Claude shared chats and Artifacts may have ended up on Google
The issue appears to have originated from Claude’s “share chat” feature, which allows users to create links that enable anyone with the assigned URL view a conversation or project.